King P. Ng

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Optimization of hypo-alloimmunogenic multispecific CAR-T and SARS-CoV-2-specific T cells for off-the-shelf adoptive cell therapy.

Optimization of hypo-alloimmunogenic multispecific CAR-T and SARS-CoV-2-specific T cells for off-the-shelf adoptive cell therapy.

Journal: Molecular therapy. Methods & clinical development
Published: October 15, 2024

An Upstream RUNX3 Enhancer, eR3 (-18m/-28h), Regulates the Development of Gut-Associated Anti-Tumorigenic CD8+CD103+ Cytotoxic T Lymphocytes in Mouse and Human.

An Upstream RUNX3 Enhancer, eR3 (-18m/-28h), Regulates the Development of Gut-Associated Anti-Tumorigenic CD8+CD103+ Cytotoxic T Lymphocytes in Mouse and Human.

Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: May 11, 2024

Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.

Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.

Journal: Experimental hematology
Published: May 06, 2024

A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection.

A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection.

Journal: Cytotherapy
Published: February 17, 2024

The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies.

The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies.

Journal: Leukemia
Published: November 27, 2023

Rapid production of clinical-grade SARS-CoV-2 specific T cells.

Rapid production of clinical-grade SARS-CoV-2 specific T cells.

Journal: Advances in cell and gene therapy
Published: June 14, 2020

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.

Journal: Blood
Published: January 10, 2020

The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.

The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.

Journal: PloS one
Published: August 08, 2018

Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.

Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.

Journal: Blood
Published: April 08, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026